Open AccessOncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
Author(s) -
Qu Deng,
Ramakrishnan Natesan,
Florencia CidreAranaz,
Shehbeel Arif,
Ying Liu,
Reyaz ur Rasool,
Pei Wang,
Erick Mitchell-Velasquez,
Chandan Kanta Das,
Endrit Vinca,
Zvi Cramer,
Patrick J. Grohar,
Margaret M. Chou,
Chandan KumarSinha,
Kristy Weber,
T.S. Karin EisingerMathason,
Nicolas Grillet,
T. Grünewald,
Irfan A. Asangani
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110971
Subject(s) - biology , enhancer , pediatric cancer , transcription factor , cancer research , gene silencing , gene isoform , fli1 , sarcoma , metastasis , gene , cancer , genetics , medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom